Cargando…

Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome

BACKGROUND: The primary aim was to explore the concept of isolated and combined threshold-insults for brain tissue oxygenation (pbtO(2)) in relation to outcome in traumatic brain injury (TBI). METHODS: A total of 239 TBI patients with data on clinical outcome (GOS) and intracranial pressure (ICP) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Svedung Wettervik, Teodor, Beqiri, Erta, Hånell, Anders, Bögli, Stefan Yu, Placek, Michal, Guilfoyle, Mathew R., Helmy, Adel, Lavinio, Andrea, O’Leary, Ronan, Hutchinson, Peter J., Smielewski, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523606/
https://www.ncbi.nlm.nih.gov/pubmed/37752602
http://dx.doi.org/10.1186/s13054-023-04659-4
_version_ 1785110596357718016
author Svedung Wettervik, Teodor
Beqiri, Erta
Hånell, Anders
Bögli, Stefan Yu
Placek, Michal
Guilfoyle, Mathew R.
Helmy, Adel
Lavinio, Andrea
O’Leary, Ronan
Hutchinson, Peter J.
Smielewski, Peter
author_facet Svedung Wettervik, Teodor
Beqiri, Erta
Hånell, Anders
Bögli, Stefan Yu
Placek, Michal
Guilfoyle, Mathew R.
Helmy, Adel
Lavinio, Andrea
O’Leary, Ronan
Hutchinson, Peter J.
Smielewski, Peter
author_sort Svedung Wettervik, Teodor
collection PubMed
description BACKGROUND: The primary aim was to explore the concept of isolated and combined threshold-insults for brain tissue oxygenation (pbtO(2)) in relation to outcome in traumatic brain injury (TBI). METHODS: A total of 239 TBI patients with data on clinical outcome (GOS) and intracranial pressure (ICP) and pbtO(2) monitoring for at least 12 h, who had been treated at the neurocritical care unit, Addenbrooke’s Hospital, Cambridge, UK, between 2002 and 2022 were included. Outcome was dichotomised into favourable/unfavourable (GOS 4–5/1–3) and survival/mortality (GOS 2–5/1). PbtO(2) was studied over the entire monitoring period. Thresholds were analysed in relation to outcome based on median and mean values, percentage of time and dose per hour below critical values and visualised as the combined insult intensity and duration. RESULTS: Median pbtO(2) was slightly, but not significantly, associated with outcome. A pbtO(2) threshold at 25 and 20 mmHg, respectively, yielded the highest x(2) when dichotomised for favourable/unfavourable outcome and mortality/survival in chi-square analyses. A higher dose and higher percentage of time spent with pbtO(2) below 25 mmHg as well as lower thresholds were associated with unfavourable outcome, but not mortality. In a combined insult intensity and duration analysis, there was a transition from favourable towards unfavourable outcome when pbtO(2) went below 25–30 mmHg for 30 min and similar transitions occurred for shorter durations when the intensity was higher. Although these insults were rare, pbtO(2) under 15 mmHg was more strongly associated with unfavourable outcome if, concurrently, ICP was above 20 mmHg, cerebral perfusion pressure below 60 mmHg, or pressure reactivity index above 0.30 than if these variables were not deranged. In a multiple logistic regression, a higher percentage of monitoring time with pbtO(2) < 15 mmHg was associated with a higher rate of unfavourable outcome. CONCLUSIONS: Low pbtO(2), under 25 mmHg and particularly below 15 mmHg, for longer durations and in combination with disturbances in global cerebral physiological variables were associated with poor outcome and may indicate detrimental ischaemic hypoxia. Prospective trials are needed to determine if pbtO(2)-directed therapy is beneficial, at what individualised pbtO(2) threshold therapies are warranted, and how this may depend on the presence/absence of concurrent cerebral physiological disturbances.
format Online
Article
Text
id pubmed-10523606
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105236062023-09-28 Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome Svedung Wettervik, Teodor Beqiri, Erta Hånell, Anders Bögli, Stefan Yu Placek, Michal Guilfoyle, Mathew R. Helmy, Adel Lavinio, Andrea O’Leary, Ronan Hutchinson, Peter J. Smielewski, Peter Crit Care Research BACKGROUND: The primary aim was to explore the concept of isolated and combined threshold-insults for brain tissue oxygenation (pbtO(2)) in relation to outcome in traumatic brain injury (TBI). METHODS: A total of 239 TBI patients with data on clinical outcome (GOS) and intracranial pressure (ICP) and pbtO(2) monitoring for at least 12 h, who had been treated at the neurocritical care unit, Addenbrooke’s Hospital, Cambridge, UK, between 2002 and 2022 were included. Outcome was dichotomised into favourable/unfavourable (GOS 4–5/1–3) and survival/mortality (GOS 2–5/1). PbtO(2) was studied over the entire monitoring period. Thresholds were analysed in relation to outcome based on median and mean values, percentage of time and dose per hour below critical values and visualised as the combined insult intensity and duration. RESULTS: Median pbtO(2) was slightly, but not significantly, associated with outcome. A pbtO(2) threshold at 25 and 20 mmHg, respectively, yielded the highest x(2) when dichotomised for favourable/unfavourable outcome and mortality/survival in chi-square analyses. A higher dose and higher percentage of time spent with pbtO(2) below 25 mmHg as well as lower thresholds were associated with unfavourable outcome, but not mortality. In a combined insult intensity and duration analysis, there was a transition from favourable towards unfavourable outcome when pbtO(2) went below 25–30 mmHg for 30 min and similar transitions occurred for shorter durations when the intensity was higher. Although these insults were rare, pbtO(2) under 15 mmHg was more strongly associated with unfavourable outcome if, concurrently, ICP was above 20 mmHg, cerebral perfusion pressure below 60 mmHg, or pressure reactivity index above 0.30 than if these variables were not deranged. In a multiple logistic regression, a higher percentage of monitoring time with pbtO(2) < 15 mmHg was associated with a higher rate of unfavourable outcome. CONCLUSIONS: Low pbtO(2), under 25 mmHg and particularly below 15 mmHg, for longer durations and in combination with disturbances in global cerebral physiological variables were associated with poor outcome and may indicate detrimental ischaemic hypoxia. Prospective trials are needed to determine if pbtO(2)-directed therapy is beneficial, at what individualised pbtO(2) threshold therapies are warranted, and how this may depend on the presence/absence of concurrent cerebral physiological disturbances. BioMed Central 2023-09-26 /pmc/articles/PMC10523606/ /pubmed/37752602 http://dx.doi.org/10.1186/s13054-023-04659-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Svedung Wettervik, Teodor
Beqiri, Erta
Hånell, Anders
Bögli, Stefan Yu
Placek, Michal
Guilfoyle, Mathew R.
Helmy, Adel
Lavinio, Andrea
O’Leary, Ronan
Hutchinson, Peter J.
Smielewski, Peter
Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome
title Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome
title_full Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome
title_fullStr Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome
title_full_unstemmed Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome
title_short Brain tissue oxygen monitoring in traumatic brain injury—part II: isolated and combined insults in relation to outcome
title_sort brain tissue oxygen monitoring in traumatic brain injury—part ii: isolated and combined insults in relation to outcome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523606/
https://www.ncbi.nlm.nih.gov/pubmed/37752602
http://dx.doi.org/10.1186/s13054-023-04659-4
work_keys_str_mv AT svedungwettervikteodor braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT beqirierta braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT hanellanders braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT boglistefanyu braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT placekmichal braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT guilfoylemathewr braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT helmyadel braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT lavinioandrea braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT olearyronan braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT hutchinsonpeterj braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome
AT smielewskipeter braintissueoxygenmonitoringintraumaticbraininjurypartiiisolatedandcombinedinsultsinrelationtooutcome